|Injections||Cell type||Admission date||Discharge date|
Condition On Admission
The patient suffered from a stroke in July 2016. Before receiving stem cell treatment, the patient had mild spasticity in the upper right limb with loss of movement, muscle weakness in the upper and lower limbs, and she had difficulty speaking. Before starting treatment, the patient had given up hope on regaining arm movement.
The patient received 6 umbilical cord blood-derived stem cell (UCBSC) packets by intravenous infusion (IV) and Intrathecal Injection (LP), as per the schedule below:
|Number||Date||Cell Type||Delivery Method||Side Effects|
|1||2019-02-18||UCBSC||Intravenous Injection||none reported|
|2||2019-02-22||UCBSC||Intrathecal Injection||none reported|
|3||2019-02-25||UCBSC||Intrathecal Injection||none reported|
|4||2019-03-01||UCBSC||Intrathecal Injection||none reported|
|5||2019-03-05||UCBSC||Intrathecal Injection||none reported|
|6||2019-03-08||UCBSC||Intravenous Injection||none reported|
Condition 3 months after treatment
3 months after the treatment, significant improvements in speech and spasticity in the arms have already been noticed. The patient still had difficulty moving her arm and had no movements in her hand and fingers. However, her doctors believe that she has a good chance of improving more, taking into account the progress she has already made.
Parents’ Assessment of Improvement
Fine hand movements
Control of movement